Abstract
I read with interest the article by Baars et al. These authors studied the prevalence and severity of mucosal inflammation in patients with ulcerative colitis (UC) and Crohn’s disease (CD) while in clinical remission. In addition, during follow-up they studied whether their findings impacted therapeutic strategies and disease course. Approximately one-third of patients had an intact mucosa at first endoscopy while one-third had endoscopic and histologic lesions and another third only histologic lesions. In most patients, in the authors’ centers, therapeutic strategy was not changed after endoscopy. Although in the long term mucosal inflammation fluctuated among the different groups (with and without initial lesions), the same was not associated with more frequent clinical relapses or stricture formation/ need for surgery. There were essentially no differences between patients with CD and UC...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
